Your search for evid returned 107 results

Most men with localized prostate cancer do not die within 15 years, whether or not they receive active surveillance or treatment.

Odds ratios for postoperative outcomes not significantly increased for those with infection in preoperative days 1 to 30, 31 to 60.

If approved, Opill would be the first daily oral contraceptive pill available without a prescription.

Low or very low confidence in evidence for reduced pain intensity after treatment with various meds, med combos

Novo Nordisk plans to file for regulatory approval of the 25mg and 50mg dosage strengths in 2023.

Treatment with dupilumab led to a significant 30% reduction in moderate or severe acute COPD exacerbations.

Tofersen is an investigational antisense medicine that reduces the synthesis of SOD1 protein production.

Rezzayo is expected to be available in the summer of 2023.

Pulmonary function tests may be beneficial every six months, may be of use in initiating noninvasive ventilation when indicated

An FDA panel has voted in favor of the safety and effectiveness of Paxlovid for COVID-19.